Uric Acid in Parkinson's Disease: What Is the Connection?

Mov Disord. 2022 Nov;37(11):2173-2183. doi: 10.1002/mds.29209. Epub 2022 Sep 3.

Abstract

Numerous studies have linked Parkinson's disease (PD) with low levels of uric acid (UA). Low UA has been associated with the risk of developing PD, and its progression and severity. The biological mechanisms underlying these relationships have never been firmly established. The most frequently proposed mechanism is that UA is an antioxidant. Low UA is thought to predispose to oxidative stress, which contributes to dopamine neuron degeneration, and leads to initial appearance of symptoms of PD and its worsening over time. Several recent studies have questioned this explanation. In this review, we describe the biology of UA, its many links with PD, evidence regarding UA as an antioxidant, and we question whether UA causes PD or contributes to its progression. We also address the possibility that something about PD causes low UA (reverse causation) or that low UA is a biomarker of some other more relevant mechanism in PD. We hope the evidence provided here will stimulate additional studies to better understand the links between UA and PD. Elucidating these mechanisms remains important, because they may provide new insights into the pathogenesis of PD or novel approaches to treatments. © 2022 International Parkinson and Movement Disorder Society.

Keywords: Parkinson′s disease; antioxidant; reactive oxidant species; urate; uric acid.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't
  • Research Support, N.I.H., Extramural

MeSH terms

  • Antioxidants
  • Biomarkers
  • Humans
  • Oxidative Stress
  • Parkinson Disease* / complications
  • Uric Acid*

Substances

  • Uric Acid
  • Antioxidants
  • Biomarkers